Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size calculations in studies using the EuroQol 5D.

M Roset1, X Badia, N E Mayo

  • 1Catalan Institute of Public Health, University of Barcelona, Spain. mroset@bell.ub.es

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|November 5, 1999
PubMed
Summary

Calculating sample sizes for health-related quality of life (HRQoL) studies using the EuroQol-5D (EQ-5D) requires careful consideration of data categorization and statistical methods. This guide helps researchers determine appropriate sample sizes for comparative trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment patterns and outcomes of patients with complex Crohn's perianal fistula in five European countries: the PREFACE study.

Acta gastro-enterologica Belgica·2025
Same author

A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Current oncology (Toronto, Ont.)·2020
Same author

Current level of technology use, health and eHealth literacy in older Canadians with a recent fracture-a survey in orthopedic clinics.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020

Area of Science:

  • Health Economics
  • Clinical Trials Methodology
  • Psychometrics

Background:

  • Health-related quality of life (HRQoL) instruments are crucial outcome measures in clinical trials.
  • Accurate sample size calculations are essential for the validity of HRQoL-based trial results.
  • The EuroQol-5D (EQ-5D) is a widely used HRQoL instrument requiring specific guidance for sample size determination.

Purpose of the Study:

  • To provide a comprehensive guide for sample size calculations using the EuroQol-5D (EQ-5D) instrument.
  • To compare sample size requirements across different EQ-5D components (descriptive system, VAS, index).
  • To evaluate the impact of data categorization and statistical methods (parametric vs. non-parametric) on sample size calculations.

Main Methods:

  • Utilized scores from general population and critically ill patient reference groups.

Related Experiment Videos

  • Analyzed sample size requirements for comparative studies.
  • Compared different categorization methods for EQ-5D variables (binary, three-level, predefined intervals, score frequency).
  • Assessed parametric and non-parametric statistical approaches.

    • Main Results:

    • Using the EQ-5D descriptive system with two categories (problems/no problems) requires higher or equal sample sizes compared to three severity levels.
    • Three-level categorization is suitable for ill populations; two-level for healthier populations.
    • Parametric approach is recommended for Visual Analogue Scale (VAS) data due to slight skewness.
    • EQ-5D index sample sizes were higher with predefined intervals versus score frequency categorization in the general population.
    • Parametric methods are recommended for the EQ-5D index in ill populations, while non-parametric methods are suitable for healthier populations.

    Conclusions:

    • Sample size calculations for EQ-5D in clinical trials depend significantly on the chosen variable categorization and statistical approach.
    • Recommendations are provided for optimizing sample size calculations based on population characteristics (ill vs. healthy) and EQ-5D component.
    • This guide facilitates robust sample size planning for comparative HRQoL studies using the EQ-5D.